These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5546282)

  • 1. Food and Drug Administration: is protecting lives the priority?
    Bazell RJ
    Science; 1971 Apr; 172(3978):41-3. PubMed ID: 5546282
    [No Abstract]   [Full Text] [Related]  

  • 2. Nationwide epidemic of septicemia caused by contaminated intravenous products. I. Epidemiologic and clinical features.
    Maki DG; Rhame FS; Mackel DC; Bennett JV
    Am J Med; 1976 Apr; 60(4):471-85. PubMed ID: 1274981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA action on blood poisoning.
    Edwards CC; Bazell RJ
    Science; 1971 Jul; 173(3995):379. PubMed ID: 5557318
    [No Abstract]   [Full Text] [Related]  

  • 4. [A bacteremia epidemic caused by contaminated prednisolone-heparin ampules].
    van Raalte RF; Boom FA; Paalman AC; Pauw W; Stout-Zonneveld A
    Ned Tijdschr Geneeskd; 1981 Jun; 125(24):952-6. PubMed ID: 7254374
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial: Microbiological hazards of intravenous infusions.
    Lancet; 1974 Mar; 1(7857):543-4. PubMed ID: 4131978
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of nationwide nosocomial infection surveillance in detecting epidemic bacteremia due to contaminated intravenous fluids.
    Goldmann DA; Dixon RE; Fulkerson CC; Maki DG; Martin SM; Bennett JV
    Am J Epidemiol; 1978 Sep; 108(3):207-13. PubMed ID: 707489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hazards associated with parenteral therapy.
    Turco SJ
    Bull Parenter Drug Assoc; 1974; 28(4):197-204. PubMed ID: 4852222
    [No Abstract]   [Full Text] [Related]  

  • 8. Current approaches in leak testing pharmaceutical packages.
    Guazzo DM
    PDA J Pharm Sci Technol; 1996; 50(6):378-85. PubMed ID: 9038084
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of infections from intravenous infusions.
    Med Lett Drugs Ther; 1973 Dec; 15(26):105-7. PubMed ID: 4203094
    [No Abstract]   [Full Text] [Related]  

  • 10. [Incidence of bacteremia and thrombophlebitis in 4 Italian hospitals and their association with the use of intravenous sets].
    Moro ML; Marchiaro G; Rigoli E; Schioppa F; Guerra C; Orefici G; Greco D
    Ann Ist Super Sanita; 1983; 19(2-3):405-11. PubMed ID: 6681231
    [No Abstract]   [Full Text] [Related]  

  • 11. The microbial contamination of intravenous infusions during clinical use.
    Holmes CJ; Allwood MC
    J Appl Bacteriol; 1979 Apr; 46(2):247-67. PubMed ID: 110761
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of safety packaging on aspirin ingestion by children.
    Clarke A; Walton WW
    Pediatrics; 1979 May; 63(5):687-93. PubMed ID: 440889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemic of gram-negative organism septicemia subsequent to elective operation.
    Sack RA
    Am J Obstet Gynecol; 1970 Jun; 107(3):394-9. PubMed ID: 5445010
    [No Abstract]   [Full Text] [Related]  

  • 14. Recommendations to pharmacists for solving problems with large-volume parenterals.
    Am J Hosp Pharm; 1976 Mar; 33(3):231-6. PubMed ID: 816199
    [No Abstract]   [Full Text] [Related]  

  • 15. Conflicts of interest. WHO and the pandemic flu "conspiracies".
    Cohen D; Carter P
    BMJ; 2010 Jun; 340():c2912. PubMed ID: 20525679
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of the federal Government in health and medical affairs.
    Lee PR
    N Engl J Med; 1968 Nov; 279(21):1139-47. PubMed ID: 5686482
    [No Abstract]   [Full Text] [Related]  

  • 17. Nationwide epidemic of septicemia caused by contaminated infusion products. IV. Growth of microbial pathogens in fluids for intravenous infusions.
    Maki DG; Martin WT
    J Infect Dis; 1975 Mar; 131(3):267-72. PubMed ID: 236343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The advisory role of FDA district offices in the planning of a new parenteral facility.
    Tetzlaff RF
    J Parenter Sci Technol; 1984; 38(3):94-7. PubMed ID: 6747781
    [No Abstract]   [Full Text] [Related]  

  • 19. Federal health programs: a major reorganization is under way.
    Boffey PM
    Science; 1968 Jun; 160(3835):1429-31. PubMed ID: 5654052
    [No Abstract]   [Full Text] [Related]  

  • 20. DuVal: giving the job of "top doctor" some substance.
    Culliton BJ
    Science; 1972 Sep; 177(4053):976-7. PubMed ID: 4560238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.